Anges Québec partners in funding of Laurent Pharmaceuticals
Members of angel network Anges Québec have partnered with Aligo Innovation LP, private investors, and Cystic Fibrosis Canada in an undisclosed financing of Laurent Pharmaceuticals Inc. Based in Montréal, Laurent is a biopharmaceutical company focused on developing a drug (LAU-7b) that aims to treat the compromised immune-inflammatory response in cystic fibrosis. The proceeds of the round will support the company's preparations for a Phase II clinical trial of the drug. Laurent was founded in 2012.
6 April 2016•3 mins read
